Literature DB >> 8836281

Seizure control following surgery in supratentorial cavernous malformations: a retrospective study in 77 patients.

D Zevgaridis1, V van Velthoven, U Ebeling, H J Reulen.   

Abstract

Of 168 patients operated on consecutively for a supratentorial cavernous malformation, 77 had seizures as the initial symptom. The effectiveness of surgery in controlling seizures and the risk of surgery were evaluated by retrospective review of the patients' charts. The follow-up period was 1 to 9 years (mean 39 months) and the review period totalled 284 lesion-years. Only two patients showed postoperative deterioration in neurological status (morbidity risk: 2.6%), no patient died (mortality: 0%). Sixty-eight (88.3%) patients were seizure-free after operation and five (6.5%) showed a marked reduction in the frequency of their seizures. This corresponds to an overall positive effect of surgery of 94.8% of the patients. There was no substantial evidence that excision of the haemosiderin-stained tissue around the cavernoma along with the lesion itself provided better results than resection of only the cavernoma. Better results with regard to seizure control, however, were associated with shorter duration of symptoms before surgery.

Entities:  

Mesh:

Year:  1996        PMID: 8836281     DOI: 10.1007/bf01411470

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  36 in total

1.  Intracranial cavernous angiomas: diagnosis and therapy.

Authors:  P A Frima-Verhoeven; A A Op de Coul; C C Tijssen; B Maat
Journal:  Eur Neurol       Date:  1989       Impact factor: 1.710

2.  The MRI appearance of cavernous malformations (angiomas).

Authors:  D Rigamonti; B P Drayer; P C Johnson; M N Hadley; J Zabramski; R F Spetzler
Journal:  J Neurosurg       Date:  1987-10       Impact factor: 5.115

3.  Angiography in intracranial cavernous hemangiomas.

Authors:  H Bogren; C Svalander; I Wickbom
Journal:  Acta Radiol Diagn (Stockh)       Date:  1970-03

4.  Occult cerebral vascular malformations: high-field MR imaging.

Authors:  J M Gomori; R I Grossman; H I Goldberg; D B Hackney; R A Zimmerman; L T Bilaniuk
Journal:  Radiology       Date:  1986-03       Impact factor: 11.105

5.  Cavernomas of the central nervous system: clinical syndromes, CT scan diagnosis, and prognosis after surgical treatment in 25 cases.

Authors:  J Vaquero; J Salazar; R Martínez; P Martínez; G Bravo
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

6.  The pathology of vascular ("arteriovenous") malformations.

Authors:  W F McCormick
Journal:  J Neurosurg       Date:  1966-04       Impact factor: 5.115

7.  Management of cerebral cavernous angiomas in children presenting with seizures.

Authors:  M J Buckingham; K R Crone; W S Ball; T S Berger
Journal:  Childs Nerv Syst       Date:  1989-12       Impact factor: 1.475

8.  Hemorrhage and epilepsy in cryptic cerebrovascular malformations.

Authors:  H J Steiger; J M Tew
Journal:  Arch Neurol       Date:  1984-07

9.  Proposal for classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy.

Authors: 
Journal:  Epilepsia       Date:  1985 May-Jun       Impact factor: 5.864

10.  Angiographically occult vascular malformations in childhood.

Authors:  E G el-Gohary; T Tomita; F A Gutierrez; D G McLone
Journal:  Neurosurgery       Date:  1987-05       Impact factor: 4.654

View more
  12 in total

Review 1.  Should we resect peri-lesional hemosiderin deposits when performing lesionectomy in patients with cavernoma-related epilepsy (CRE)?

Authors:  P Dammann; C Schaller; U Sure
Journal:  Neurosurg Rev       Date:  2016-11-08       Impact factor: 3.042

Review 2.  Supratentorial cavernous haemangiomas and epilepsy: a review of the literature and case series.

Authors:  N F Moran; D R Fish; N Kitchen; S Shorvon; B E Kendall; J M Stevens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-05       Impact factor: 10.154

Review 3.  Cavernomas of the central nervous system in children. A report of 22 cases.

Authors:  C Di Rocco; A Iannelli; G Tamburrini
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

4.  Magnetoencephalography (MEG) predicts focal epileptogenicity in cavernomas.

Authors:  H Stefan; G Scheler; C Hummel; J Walter; J Romstöck; M Buchfelder; I Blümcke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

Review 5.  Rates and predictors of seizure freedom in resective epilepsy surgery: an update.

Authors:  Dario J Englot; Edward F Chang
Journal:  Neurosurg Rev       Date:  2014-02-05       Impact factor: 3.042

6.  Phase I trial: safety and feasibility of intracranial electroencephalography using hybrid subdural electrodes containing macro- and microelectrode arrays.

Authors:  Jamie J Van Gompel; S Matthew Stead; Caterina Giannini; Fredric B Meyer; W Richard Marsh; Todd Fountain; Elson So; Aaron Cohen-Gadol; Kendall H Lee; Gregory A Worrell
Journal:  Neurosurg Focus       Date:  2008-09       Impact factor: 4.047

7.  Surgical management of cavernous malformations presenting with drug-resistant epilepsy.

Authors:  Mario Arturo Alonso-Vanegas; José M Cisneros-Franco; Taisuke Otsuki
Journal:  Front Neurol       Date:  2012-01-03       Impact factor: 4.003

8.  The Role of Hemosiderin Excision in Seizure Outcome in Cerebral Cavernous Malformation Surgery: A Systematic Review and Meta-Analysis.

Authors:  Di Ruan; Xiao-Bo Yu; Sudeep Shrestha; Lin Wang; Gao Chen
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

9.  Microsurgical treatment and outcome of pediatric supratentorial cerebral cavernous malformation.

Authors:  Jung-Hoon Noh; Kyung Rae Cho; Je Young Yeon; Ho Jun Seol; Hyung Jin Shin
Journal:  J Korean Neurosurg Soc       Date:  2014-09-30

10.  Technical, Anatomical, and Functional Study after Removal of a Symptomatic Cavernous Angioma Located in Deep Wernicke's Territories with Cortico-Subcortical Awake Mapping.

Authors:  Silvio Sarubbo; Gianpaolo Basso; Franco Chioffi; Edward Cesnik; Beatrice Paradiso; Enrico Grandi; Enrico Fainardi; Valeria Tugnoli; Marco Farneti; Enrico Granieri
Journal:  Case Rep Neurol Med       Date:  2013-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.